Trademark: 97224329
Status Date
Tuesday, April 9, 2024
Filing Date
Tuesday, January 18, 2022
Published for Opposition
Tuesday, February 13, 2024
5 Biological, biochemical and chemical substances and preparations for clinical, diagnostic, medical, and therapeutic use, namely, for nucleic acid vaccine preparations to treat genetic disorders using gene modulation and gene expression therapies
Apr 9, 2024
Noa E-Mailed - Sou Required From Applicant
Feb 13, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 13, 2024
Published For Opposition
Jan 24, 2024
Notification Of Notice Of Publication E-Mailed
Jan 9, 2024
Exparte Appeal Terminated
Jan 9, 2024
Approved For Pub - Principal Register
Jan 9, 2024
Teas/Email Correspondence Entered
Jan 9, 2024
Correspondence Received In Law Office
Dec 14, 2023
Teas Request For Reconsideration Received
Dec 15, 2023
Ex Parte Appeal-Instituted
Dec 15, 2023
Jurisdiction Restored To Examining Attorney
Dec 15, 2023
Exparte Appeal Received At Ttab
Sep 13, 2023
Application Extension Granted/Receipt Provided
Sep 13, 2023
Application Extension To Response Period - Received
Jun 14, 2023
Notification Of Final Refusal Emailed
Jun 14, 2023
Final Refusal E-Mailed
Jun 14, 2023
Final Refusal Written
May 9, 2023
Teas/Email Correspondence Entered
May 8, 2023
Correspondence Received In Law Office
May 8, 2023
Teas Response To Office Action Received
Nov 8, 2022
Notification Of Non-Final Action E-Mailed
Nov 8, 2022
Non-Final Action E-Mailed
Nov 8, 2022
Non-Final Action Written
Oct 26, 2022
Assigned To Examiner
Mar 31, 2022
Petition To Director Denied
Mar 31, 2022
Petition To Director Denied
Mar 29, 2022
Assigned To Petition Staff
Mar 24, 2022
Teas Petition To Director Received
Jan 24, 2022
New Application Office Supplied Data Entered
Jan 21, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
